Filing Flows › Clover Health Investments (CLOV) › Q2 2026
Clover Health Investments (CLOV) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 7, 2026
Clover Health Investments (CLOV) reported revenue of $743M for the second quarter 2026 (Q2 2026), +56% from a year earlier and -0.8% from the quarter before. Operating margin was 3.8%, net earnings $28.0M (3.8% of revenue).
Clover Health Investments, Q2 2026: revenue $743M (+56% year over year), operating margin 3.8%, net earnings $28.0M, operating cash flow $25.2M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $743M | -0.8% | +56% |
| Operating profit | $28.0M | +2% | — |
| Net earnings | $28.0M | +2% | — |
| Operating cash flow | $25.2M | -77% | +366% |
| Free cash flow | $24.5M | -77% | +406% |
What changed
Revenue was $743.2M in Q2 2026, up 56% year over year and down 1% from the previous quarter.
Operating profit was $28.0M, a 3.8% margin (up 6.0 points year over year). Total costs grew 46% against revenue growth of 56%. The fastest-growing cost line was Other operating costs (+47%). Net earnings were $28.0M. The effective tax rate was 0.0%.
Operating cash flow was $25.2M (up 366% year over year), 90% of net earnings. Non-cash charges added back $9.1M of share-based compensation. Working capital and other items used $11.9M. Capital expenditures of $682K left free cash flow of $24.5M.
Questions
What was Clover Health Investments' revenue in the second quarter 2026?
Clover Health Investments (CLOV) reported revenue of $743M for the second quarter 2026 (Q2 2026), +56% from a year earlier and -0.8% from the quarter before.
Was Clover Health Investments profitable in the second quarter 2026?
Operating profit was $28.0M (3.8% of revenue) and net earnings $28.0M.